Traditionally, common weight loss operations have been categorized as malabsorptive, restrictive, or a combination of these. Malabsorptive procedures induce weight loss by bypassing segments of the small intestine, thus decreasing nutrient absorption. 8 Restrictive procedures promote weight loss by limiting food intake. 8, 9 Previous research indicates a higher prevalence of nutrient deficiencies following malabsorptive compared with restrictive procedures. 9 In contrast with previous research, recent studies have found similar proportions of nutrient deficiency following sleeve gastrectomy (SG), considered a primarily restrictive procedure, compared with Roux-en-Y gastric bypass (RYGB), a procedure encompassing both recognized malabsorptive and restrictive features. 10, 11 While SG was previously considered mainly restrictive, the removal of 60%-80% of the stomach may lead to deficiencies in gastric acid and intrinsic factor-secreting 690521N CPXXX10.1177/0884533617690521Nutrition in Clinical PracticeGoldberg et al
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From the 1 parietal cells necessary for effective absorption of iron, B 12 , and folate. [12] [13] [14] It is therefore plausible that SG encompasses malabsorptive characteristics.
To assess if routine multivitamin/mineral supplementation is sufficient to prevent anemia in adolescent patients undergoing bariatric surgery, this study examined and compared anemia marker levels (iron, ferritin, B 12 , folate, hemoglobin [Hgb] , and hematocrit [Hct] ) following SG with those following LAGB, a purely restrictive procedure. We hypothesized that patients undergoing SG would present with greater reductions in anemia markers than those who undergo LAGB, due to the potential malabsorptive characteristics of the procedure, and will therefore require additional multivitamin/mineral supplementation.
Methods

Patients
In total, 175 patients who underwent LAGB (141 patients) or SG (34 patients) at an academic institution between January 2006 and December 2013 were included in this study. Patients received nutrition and exercise counseling prior to surgery. From 2006-2010, patients were offered LAGB as the surgical procedure. Beginning in 2010, a gradual transition to SG began, and since 2011, patients were offered almost exclusively SG. This change resulted from changes in clinical practice as SG increased in popularity among bariatric surgeons. The same surgeon performed all surgeries. This study was approved by the institutional review board. All patients and their parents or legal guardian gave written informed consent and assent for ongoing collection of data prospectively in the bariatric program prior to participation.
Clinical Assessments
Physical examination and biological analyses were routinely performed on patients prior to surgery at the initial visit, in addition to 3 months, 6 months, and 12 months postsurgery. Patient demographic, physical, and biological data were recorded from the patient medical record. In a retrospective review of medical records, a database was constructed, recording the patients' age, sex, height, weight, body mass index (BMI), and iron, ferritin, B 12 , folate, Hgb, and Hct levels at each visit. Prespecified primary outcomes included changes within groups and differences between groups in anemia marker levels, including, iron, ferritin, B 12 , folate, Hgb, and Hct postsurgery, over a 12-month period.
Multivitamin/Mineral Supplement Protocol
All patients were advised to take an over-the-counter multivitamin/ mineral supplement containing iron once per day following surgery. Brand or type of multivitamin was not specified. Compliance was monitored by serial measurements of serum levels. Low values of iron, B 12 , or folate were supplemented as follows: if the patient was iron deficient without anemia, a multivitamin/mineral containing 15-18 mg iron was prescribed. If iron deficient with anemia, 75 mg iron was prescribed once or twice daily for 2-4 months, or 150 mg iron was prescribed once or twice daily for 2 months and then switched to a multivitamin/mineral containing 15-18 mg iron/d. If the patient was B 12 deficient without signs of pernicious anemia, 1000 µg intramuscular B 12 was prescribed once per week for 4 weeks, and then the patient was switched to 100 µg sublingual oral B 12 once per day for maintenance. If the patient was folate deficient without signs of macrocytic anemia, 400 µg folate was prescribed per day. If folate deficient with macrocytic anemia, 1000 µg folate was prescribed per day until anemia resolved and folate levels returned to normal.
Assessment of Anemia Marker Levels
The clinical chemistry laboratory measured iron and ferritin by a liquid chemistry assay (Olympus AU2700, Olympus America, Inc, Melville, NY). The specialty laboratory measured B 12 and folate by chemiluminescence (Elecsys 2010, Roche Diagnostics, Indianapolis, IN). The hematology laboratory measured Hgb and Hct using Sysmex XE-5000 (Sysmex America Inc, Lincolnshire, IL) instruments. Reference ranges indicated by the clinical laboratory determined low anemia marker level cutoffs.
Statistical Analysis
The results of this study are reported as means and standard deviations unless otherwise noted. Differences between group means at baseline were assessed with independent t tests. Differences in frequencies were assessed with χ 2 or Fisher's exact tests. To analyze group differences in the absolute level or percent change in anemia marker levels over the period of follow-up, we used a linear mixed model for repeated measures for each dependent variable. Each model included fixed effects for procedure (LAGB vs SG), time (3, 6 , and 12 months postsurgery), and procedure-by-time interaction with the presurgical level of the dependent variable entered as a continuous covariate. Analyses also employed percent weight loss from baseline as a time-dependent covariate. An autoregressive integrated moving average covariance structure was empirically determined to best fit the within-subject autocorrelation. Modelestimated means, standard errors, and 95% confidence intervals were used to compare the procedure's effect on each dependent variable at a specific time. To evaluate the potential for bias from dropout, we used t tests and χ 2 tests to assess whether baseline characteristics correlated with patients' completing follow-up. The same linear mixed models were applied to the subset of patients completing the study to examine if the analysis results would be biased by patients' dropout. We performed all analyses using SAS version 9.4 (SAS Institute, Cary, NC). P < .05 was used as the minimum level of statistical significance.
Results
Baseline Characteristics
Mean age, weight, height, BMI, and sex distribution and ethnicity are listed in Table 1 . All patients were Tanner 4 or 5 pubertal stages. There were no differences in baseline characteristics except in ethnic distribution (P = .03) between the LAGB and SG groups (Table 1) .
There were no differences in frequency of patients who presented with low anemia marker levels at the initial visit between the LAGB and SG groups. Iron deficiency was present in 22% of patients in each group, and low Hgb was present in 15% and 24% (P = .3) of patients in the LAGB and SG groups, respectively. Deficiency for each nutrient was defined using the following cutoffs (conversion factor for International System of Units in parentheses (Table 2) .
There were no differences in anemia marker levels (iron, ferritin, B12, folate, Hgb, or Hct) at the initial visit between the LAGB and SG groups (Table 3) .
Anemia Marker Levels Postsurgery
Within-group differences in anemia marker levels. Folate levels were lower 3 and 6 months post-SG compared with the initial visit, but they returned to baseline levels at 12 months. B 12 levels were lower 6 months post-SG compared with 3 months, although not different from levels at the initial visit, and they returned to baseline levels at 12 months. There were no changes in iron, ferritin, Hgb, or Hct following SG at long-term time points (Table 3) .
There were no changes in folate at any time point post-LAGB. B 12 levels were lower 12 months post-LAGB compared with levels at 6 months and levels at the initial visit. Ferritin levels were lower 3 months post-LAGB compared with the initial visit but returned to baseline levels at 6 months.
There were no changes in iron, Hgb, or Hct following LAGB at long-term time points (Table 3) .
The results from the unadjusted analysis did not differ from the adjusted for weight loss analysis with one exception: ferritin levels were lower 12 months post-SG compared with the initial visit (40.0 ± 145.1 ng/mL vs 57.8 ± 95.8, P = .03).
Between-group differences in anemia marker levels. The SG group demonstrated lower folate levels compared with the LAGB group 3 and 6 months postsurgery but showed no differences between groups at 12 months (Table 3 ). There were no other between-group differences in anemia marker levels.
Between-group differences in percent change of anemia marker levels. The SG group demonstrated a greater percent decrease in folate than the LAGB group 3 months (-31.0 ± 185.7 vs 3.6 ± 93.7, P = .006) and 6 months (-22.9 ± 174.7 vs 10.3 ± 80.4, P = .005) postsurgery compared with the initial visit ( Figure 1 ). There were no other between-group differences in percent change of anemia marker levels.
Assessment for Potential Bias From Patients Lost to Follow-Up
There was no significant association between procedure type and patients lost to follow-up or between baseline nutrient levels and patients lost to follow-up. When the statistical analysis assessing anemia marker levels was restricted to only those patients who completed the study and compared with our original analysis, there was no significant change in results.
Discussion
Bariatric surgery is the most effective method of long-term weight loss for adolescents with severe obesity. 3 Micronutrient deficiencies, however, often develop following surgery. As a result, patients commonly present with anemia. 1 To prevent deficiencies from arising, patients are advised to take multivitamin/mineral supplements. Although previous research has investigated nutrient deficiencies following bariatric surgery, the literature is not extensive enough for the development of standardized nutrition management guidelines. 7 It is known that adolescents with obesity are already at an increased risk for developing anemia preoperatively, likely due to obesity-induced chronic inflammation, which causes alterations in iron homeostasis. [15] [16] [17] [18] [19] Similarly, patients included in the current study demonstrated a high prevalence of iron deficiency and anemia (defined by low Hgb levels) prior to surgery. Thus, monitoring micronutrient levels following bariatric surgery and supplementing accordingly is crucial. Our patients were advised to take 1 tablet of an over-the-counter multivitamin/mineral supplement daily. We sought to investigate if this routine supplementation was sufficient to prevent reductions in anemia markers following bariatric surgery, particularly following SG, as this surgery may encompass malabsorptive characteristics.
Our results indicated that folate levels in SG patients were significantly reduced 3 and 6 months following surgery compared with the initial visit despite all patients being advised to take multivitamin/mineral supplements. Furthermore, folate 12 These results are consistent with previous research that found that bariatric procedures, including SG and RYGB, can be associated with folate deficiency. 20, 21 Previous research has also found that the odds of folate deficiency in the first year following bariatric surgery are higher for malabsorptive compared with restrictive surgeries, similar to our findings. 22 In our patients, identification of deficiencies resulted in recommendation for additional supplementation of that nutrient. Previous research indicates that folate deficiency can be successfully corrected with oral supplementation. 23 Our research showed that folate levels returned to baseline levels 12 months postoperatively, indicating that with monitoring and additional supplementation as needed, deficiencies can be corrected successfully.
Folate plays a major role in cell division, cell maintenance, construction and repair of DNA, and DNA methylation required for epigenetic gene expression. 24, 25 Folate deficiency can result in macrocytic anemia. 24 In addition, folate deficiency in pregnant women increases the risk of neural tube defects in offspring. 25 In our study, folate levels significantly decreased 3 and 6 months following SG. This represents a potentially serious problem as our study sample included 114 adolescent girls (65%) who are likely to become pregnant in the future. Effective supplementation is therefore critical in this group of patients. Importantly, our patient population had a high missed appointment rate. Thus, primary care practitioners need to be particularly aware that adolescent bariatric patients are at risk for folate deficiency so that they can prescribe additional supplements accordingly and manage this complication successfully. B 12 deficiency following LAGB and SG has also been previously reported. 1, 9 One study found that the prevalence of B 12 deficiency between 3 and 12 months following SG was 14%. 23 Reductions in B 12 levels can be attributed to reduced intake of B 12 -containing foods, such as meat, as well as reduced gastric acid and intrinsic factor secretion associated with malabsorptive procedures. 20 Consistent with previous research, our results indicated that B 12 levels decreased in both groups following surgery. B 12 levels were reduced 6 months post-SG compared with 3-month levels, but these were corrected by 12 months, demonstrating that additional supplementation was successful.
Interestingly, B 12 levels following LAGB were significantly reduced 12 months following surgery, but they were not reduced at earlier time points. It is likely that this reduction in B 12 relates to poor quality of eating, which is characterized by food intolerance, frequent vomiting, and subjective dissatisfaction of eating ability. 26 Previous research has shown that patients who have undergone LAGB have a lower quality of eating than patients who have undergone SG and RYGB. 26 Importantly, LAGB patients show the lowest quality of eating around 6-12 months or later following the procedure and have particular difficulty tolerating red meat. This could account for the reduction in B 12 that was demonstrated in our patient population 12 months following LAGB. 26 Future research is needed to investigate the relative contribution of malabsorption vs food intolerance to specific nutrient deficiencies following different bariatric procedures across time points to elucidate this pattern of result further.
Iron deficiency is frequently observed following bariatric surgery, with a prevalence as high as 14% and 18% following LAGB and SG, respectively. 19 However, at least 2 other studies found a very low prevalence of iron deficiency following SG. 6, 21 Similarly, our results indicated that there were no significant reductions in iron levels following surgery in either group or difference between SG and LAGB groups.
Ferritin was measured to assess levels of iron in storage. Similar to iron levels, there were no significant decreases in ferritin following SG or differences between SG and LAGB groups at any time points postsurgery. Following LAGB, ferritin was lower at 3 months compared with the initial visit but returned to baseline levels by 6 months. Our results therefore suggest that that iron stores were not reduced. 27 Hgb and Hct levels are used as indicators for anemia. 28 Previous studies have found that bariatric surgery is associated with reductions in Hgb and Hct, although levels are usually maintained within the normal range. 29, 30 Our results showed no significant reductions in Hgb and Hct levels after surgery or differences between LAGB and SG patients, which is consistent with our results on iron and ferritin levels.
The unadjusted analysis showed similar results to the adjusted analysis across all anemia marker variables, except for further reduction in ferritin in LAGB patients. This difference disappeared with the adjustment for weight loss, indicating that weight loss with associated decreased intake contributed to ferritin changes rather than the actual procedure.
To our knowledge, this study is the first to compare anemia marker levels following LAGB with those following SG in the adolescent population. This comparison provided an opportunity to examine the potential malabsorptive characteristics of SG and to assess if routine nutrient supplementation is sufficient to prevent deficiencies postoperatively. These investigations are crucial for guiding physicians in prescribing nutrition supplements and monitoring nutrient deficiencies.
We acknowledge limitations in our study. All patients included in the study were advised to take multivitamin/mineral supplements daily, although it is unclear if all patients adhered to physicians' prescription of supplements. Given the development of reduced folate and B 12 levels despite recommendation for routine supplementation, it must be concluded that patients are nonadherent or need greater amounts than are provided in a general multivitamin/mineral. Periodic monitoring for nutrient deficiencies is therefore highly important, particularly during the initial year following bariatric surgery. In addition, patients were lost to follow-up at later time points in the study, particularly at 12 months. It is possible that patients who did follow up were more likely to follow the vitamin supplement recommendations compared with those who did not follow up. To assess if patient dropout biased our results, we performed several statistical analyses. First, we found that procedure type was not associated with patients lost to follow-up. We also found no significant differences in baseline characteristics of those who completed 12-month follow-up compared with those who did not. Furthermore, when we compared the analysis of anemia marker levels based on the entire cohort to the analysis restricted to those who provided 12-month data, all previously significant findings remained and previous findings that were not significant did not attain significance. These analyses suggest a lack of impact on outcome due to loss to follow-up. However, given the need for additional supplementation demonstrated by those who did return, a potential for more significant deficiencies is possible and warrants evaluation by practitioners seeing these patients for routine health care.
Conclusion
This study shows that although anemia per se did not develop in any of our patients following surgery with recommended routine supplementation, folate levels were significantly reduced following SG and were lower in SG compared with LAGB patients. This complication is particularly concerning for female patients because of the potential impact of folate deficiency in pregnancy. Our study demonstrates that SG encompasses malabsorptive characteristics, and as a result, routine nutrient supplementation is not necessarily sufficient to prevent nutrient deficiency following bariatric surgery. Additional folate supplementation seemed to improve folate levels, which highlights the importance of ongoing surveillance by general practitioners and further folate supplementation following SG.
